FBRX Stock Summary and Trading Ideas (Forte Biosciences | NASDAQ:FBRX)

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Forte Biosciences trades on the NASDAQ stock market under the symbol FBRX.

As of January 9, 2026, FBRX stock price declined to $23.56 with 133,414 million shares trading.

FBRX has a beta of 1.80, meaning it tends to be more sensitive to market movements. FBRX has a correlation of 0.07 to the broad based SPY ETF.

FBRX has a market cap of $295.13 million. This is considered a Small Cap stock.

In the last 3 years, FBRX traded as high as $32.25 and as low as $4.11.

The top ETF exchange traded funds that FBRX belongs to (by Net Assets): VTI, VXF, ATFV, IWC, SBIO.

FBRX has outperformed the market in the last year with a return of +21.2%, while the SPY ETF gained +18.9%. In the last 3 month period, FBRX beat the market returning +64.0%, while SPY returned +3.4%. However, in the most recent 2 weeks FBRX has underperformed the stock market by returning -14.1%, while SPY returned +0.5%.

FBRX support price is $22.11 and resistance is $26.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FBRX shares will trade within this expected range on the day.